Literature DB >> 14867910

Sulfozone (diasone) sodium for dermatitis herpetiformis.

T CORNBLEET.   

Abstract

Entities:  

Keywords:  DERMATITIS HERPETIFORMIS/therapy; SULFONES/therapeutic use

Mesh：

Substances：

Year:  1951        PMID： 14867910     DOI： 10.1001/archderm.1951.01570120019003

Source DB:  PubMed          Journal:  AMA Arch Derm Syphilol        ISSN： 0096-5979


× No keyword cloud information.
  5 in total

1.  Agranulocytosis Following Dapsone Therapy.

Authors:  W B McKenna; A C Chalmers
Journal:  Br Med J       Date:  1958-02-08

2.  Recent therapeutic advances in dermatology.

Authors:  L P EREAUX
Journal:  Can Med Assoc J       Date:  1954-02       Impact factor: 8.262

3.  The Treatment of Dermatitis Herpetiformis with Diaminodiphenyl Sulphone.

Authors:  R Jackson
Journal:  Can Med Assoc J       Date:  1955-11-01       Impact factor: 8.262

4.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.

Authors:  O Stendahl; L Molin; C Dahlgren
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

5.  In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  R Anderson; E M Gatner; C E van Rensburg; G Grabow; F M Imkamp; S K Kok; A J van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.